Physician

Helbert Acosta, M.D.

According to 2025 Medicare claims, Helbert Acosta, M.D. (NPI: 1477532281) practices cardiac electrophysiology in the Davenport-Moline-Rock Island, IA-IL market, with the plurality of this provider's patient population coming from Rock Island, IL. This provider's primary affiliated billing organization is CARDIOVASCULAR MEDICINE PLLC (NPI: 1982632907; TIN: 421085919) and primary practice location at 61265-7127. Acosta is affiliated with the IRCCO (ACO ID: A2619), Genesis Accountable Care Organization, LLC. (ACO ID: A4799), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Acosta's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,746 traditional Medicare patients, billed 9,573 HCPCS/CPT codes, and received $492,808 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 6,760 prescription claims across 1,187 beneficiaries totaling $2,258,400 in drug costs, led by Eliquis (Apixaban). 2019 DME data shows 12 claims. Open Payments data shows 61 records totaling $3,984. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $768,697 to $2,258,400. In contrast, DME billing represents a smaller volume and declined steadily, from $70,370 to $25,574.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,420	12,172	$607,022
2016	1,947	11,473	$527,873
2017	1,836	13,131	$479,509
2018	1,961	12,973	$487,267
2019	2,091	12,512	$491,736
2020	1,912	9,832	$434,410
2021	2,216	11,658	$453,019
2022	1,967	8,455	$404,681
2023	1,833	10,527	$447,638
2024	1,746	9,573	$492,808

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	874	6,703	$768,697
2016	856	5,983	$872,283
2017	832	5,296	$932,937
2018	876	5,125	$1,057,061
2019	838	5,138	$1,120,163
2020	864	5,443	$1,294,815
2021	918	5,635	$1,605,548
2022	1,010	6,078	$1,840,214
2023	1,098	6,065	$2,042,865
2024	1,187	6,760	$2,258,400

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	11	34	$69,577
2016	N/R	23	$44,068
2017	N/R	19	$37,078
2018	N/R	14	$29,872
2019	N/R	12	$25,574
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	600	722	$86
93294	Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days	311	905	$20
93296	Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days	434	1,247	$14
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	914	1,379	$10
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	341	423	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	812	54,097	$1,041,977
Multaq	Dronedarone Hcl	548	29,644	$628,617
Xarelto	Rivaroxaban	229	15,515	$284,327
Entresto	Sacubitril/Valsartan	170	8,534	$182,759
Metoprolol Succinate	Metoprolol Succinate	1,185	96,287	$17,602

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	61	$3,984	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Helbert Acosta, M.D.?

Tedicare shows public-source Medicare data for Helbert Acosta, M.D. (NPI 1477532281), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Helbert Acosta, M.D. have ACO affiliation data?

Helbert Acosta, M.D. is shown with ACO affiliation data for IRCCO (MSSP, ACO ID A2619), Genesis Accountable Care Organization, LLC. (MSSP, ACO ID A4799), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Helbert Acosta, M.D.?

Helbert Acosta, M.D. is linked to CARDIOVASCULAR MEDICINE PLLC (billing NPI 1982632907) in the available physician profile data.

Does Helbert Acosta, M.D. have Open Payments data?

Helbert Acosta, M.D. has 61 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.